Skip to content

Effects of High-Definition Transcranial Alternating Current Stimulation on Patients with subjective cognitive decline

Effects and Safety of High-Definition Transcranial Alternating Current Stimulation (HD-tACS) on Cognitive Performance in Patients with subjective cognitive decline (SCD)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087327
Enrollment
Unknown
Registered
2024-07-25
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subjective cognitive decline

Interventions

Intervention group:High-definition transcranial alternating current stimulation (HD-tACS) at 40Hz with an intensity of 1.5mA, targeting the left dorsolateral prefrontal cortex (DLPFC), administered fo
Control group:the stimulator have a built-in placebo mode
electric current ramp up/down at the beginning and the end of sham stimulation in 30 s, while the rest of the session follows the same protocol as the intervention group.

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age between 50-85 years old. 2.Meet the diagnostic criteria for subjective cognitive decline. 3.Have a minimum education level of junior high school or above, with the required abilities in listening, speaking, reading, writing, and comprehension for this study. 4.Sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1.Presence of unstable systemic diseases or organ failure. 2.Any disease that causes cognitive decline, including Alzheimer's disease, vascular dementia, Parkinson's disease, epilepsy, etc. 3.Substance abuse (illegal drugs or alcohol, tobacco, etc.). 4.History of or currently undergoing electrical stimulation or other neuromodulation techniques. 5.Individuals with implanted pacemakers, cochlear implants, intracranial metal implants or devices. 6.Participation in other clinical trials simultaneously.

Design outcomes

Primary

MeasureTime frame
MoCA-Beijing;

Secondary

MeasureTime frame
auditory vocabulary learning test of Huashan version ;Wechsler Memory Scale - Logical Memory Subscale;n-back;EEG;

Countries

China

Contacts

Public ContactXiao Lu

Department of Rehabilitation Medicine, The First Affiliated Hospital of Nanjing Medical University

luxiao1972@163.com+86 138 1395 8023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026